Skip to content
10-K

Annual Report

VOR BIOPHARMA INC. VOR

0001193125-26-130451

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 23, 2026 48.85M sh
Shares Diluted FY 2025 · Dec 31, 2025 9.87M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 3.44M sh
Dividends Paid FY 2025 · Dec 31, 2025 $0
Dividends Paid FY 2025 · Dec 31, 2024 $0
Capex FY 2025 · Dec 31, 2025 $941K
Capex FY 2025 · Dec 31, 2024 $229K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$142.71M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$99.66M
Cash And Equivalents FY 2025 · Dec 31, 2025 $396.49M
Cash And Equivalents FY 2025 · Dec 31, 2024 $81.95M
Stockholders Equity FY 2025 · Dec 31, 2025 −$164.31M
Stockholders Equity FY 2025 · Dec 31, 2024 $96.66M
Stockholders Equity FY 2025 · Dec 31, 2023 $150.72M
Current Liabilities FY 2025 · Dec 31, 2025 $25.17M
Current Liabilities FY 2025 · Dec 31, 2024 $18.61M
Total Liabilities FY 2025 · Dec 31, 2025 $628.44M
Total Liabilities FY 2025 · Dec 31, 2024 $46.23M
Current Assets FY 2025 · Dec 31, 2025 $458.11M
Current Assets FY 2025 · Dec 31, 2024 $96.51M
Total Assets FY 2025 · Dec 31, 2025 $464.13M
Total Assets FY 2025 · Dec 31, 2024 $142.89M
Eps Diluted FY 2025 · Dec 31, 2025 −$70.50
Eps Diluted restated FY 2025 · Dec 31, 2024 −$34.03
Eps Basic FY 2025 · Dec 31, 2025 −$70.50
Eps Basic restated FY 2025 · Dec 31, 2024 −$34.03
Sga Expense FY 2025 · Dec 31, 2025 $50.11M
Sga Expense FY 2025 · Dec 31, 2024 $27.88M
Rd Expense FY 2025 · Dec 31, 2025 $321.53M
Rd Expense FY 2025 · Dec 31, 2024 $93.31M
Net Income FY 2025 · Dec 31, 2025 −$695.98M
Net Income FY 2025 · Dec 31, 2024 −$116.91M
Operating Income FY 2025 · Dec 31, 2025 −$371.64M
Operating Income FY 2025 · Dec 31, 2024 −$121.19M